|
2024
|
Invention
|
Treatment for bone diseases.
The invention relates to the treatment of bone disorders. In partic... |
|
2023
|
Invention
|
Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimen.
The inven... |
|
|
Invention
|
Antibodies specific for sclerostin and methods for increasing bone mineralization.
Compositions ... |
|
2022
|
Invention
|
Protein purification.
The present invention relates to a process for the purification of an anti... |
|
2020
|
Invention
|
Treatment for bone diseases. The invention relates to the treatment of bone disorders. In particu... |
|
2019
|
Invention
|
Antibodies specific for sclerostin and methods for increasing bone mineralization. Compositions a... |
|
|
G/S
|
Providing medical information on disease and disease management in the field of immunology; Medic... |
|
|
Invention
|
Protein purification. The present invention relates to a process for the purification of an antib... |
|
2018
|
G/S
|
Business administration of medication reimbursement programs and services Providing information t... |
|
|
G/S
|
Business administration of medication reimbursement programs and services Charitable services, na... |
|
2017
|
Invention
|
A specific trifluoroethyl quinoline analogue for use in the treatment of apds.
N—{(R)-1-[8-Chlor... |
|
|
Invention
|
Antibody molecules having specificity for human il-6.
The invention relates to antibody molecule... |
|
2016
|
Invention
|
Dual specificity antibody fusions. The present invention provides dual specificity antibody fusio... |
|
|
Invention
|
Bacterial host strain. A recombinant gram-negative bacterial cell comprising one or more of the f... |
|
2015
|
Invention
|
Anti-sclerostin antibodies and their use to treat bone disorders as part of a regimen. The invent... |
|
|
G/S
|
Pharmaceutical preparations, namely, preparations for the treatment of arthritis; pharmaceutical ... |
|
|
G/S
|
Pharmaceutical and veterinary products; sanitary products
for medical purposes; dietetic food an... |
|
|
Invention
|
Cassette device for administering medication |
|
|
Invention
|
Bacterial host strain expressing recombinant dsbc and having reduced tsp activity. The present in... |
|
|
Invention
|
Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene. The present inventio... |
|
|
Invention
|
Compositions and methods for increasing bone mineralization. A novel class or family of TGF-β bin... |
|
|
Invention
|
Bacterial host strain comprising a mutant spr gene and having reduced tsp activity. The present i... |
|
2014
|
Invention
|
Neutralising antibody molecules having specificity for human il-17.
The invention relates to an ... |
|
|
Invention
|
Compounds for enhancing the cognitive function. The invention relates to 2-oxo-1-pyrrolidinyl tri... |
|
|
G/S
|
Medical devices, namely injection devices for administering
medicines. |
|
|
Invention
|
Analytical method for fab and fab′ molecules. A method of measuring acidic species generated by d... |
|
|
Invention
|
Biomarkers for epilepsy.
The present invention relates to a group of epilepsy biomarkers compris... |
|
2013
|
Invention
|
Therapeutically active pyrazolo-pyrimidine derivatives. A series of pyrazolo[3,4-d]pyrimidine der... |
|
|
Invention
|
Method for identifying antibody producing cells. The present disclosure relates to a method for i... |
|
|
Invention
|
Nucleic acids encoding antibody molecules which bind il-17a and il-17f.
The invention relates to... |
|
|
G/S
|
Medical devices, namely injection devices for administering drugs. |
|
|
Invention
|
A method for identifying compounds of therapeutic interest. The present invention relates to an i... |
|
|
Invention
|
Pharmaceutical formulation.
The present invention relates to methods and means for reducing the ... |
|
|
Invention
|
Pharmaceutical formulation. The present invention relates to a methods and means for reducing the... |
|
|
Invention
|
New compound based on cinchona alkaloïds for use in asymmetric michael addition. The present inve... |
|
|
Invention
|
Anti-fcrn antibodies. The disclosure relates to antibodies specific to FcRn, formulations compris... |
|
|
Invention
|
Recombinant bacterial host cell for protein expression. The present disclosure relates to a recom... |
|
|
Invention
|
Methods for treating parkinson's disease. The invention pertains to a method of treating Parkinso... |
|
|
Invention
|
Antibody-based diagnostics and therapeutics.
Compositions and methods relating to sclerostin bin... |
|
|
Invention
|
Systems and methods for recharging an auto-injector.
Systems, devices, and methods are described... |
|
|
Invention
|
Sequence asymmetric modified igg4 bispecific antibodies. The present disclosure provides an asymm... |
|
|
Invention
|
Sequence symmetric modified igg4 bispecific antibodies. The present disclosure relates to a symme... |
|
|
Invention
|
Sequence symmetric modified igg4 bispecific antibodies. The present disclosure provides an asymme... |
|
|
G/S
|
Printed matter, namely, newsletters and brochures in the field of healthcare, published for healt... |
|
|
Invention
|
Sclerostin binding antibody. Compositions and methods relating to epitopes of sclerostin protein,... |
|
2012
|
Invention
|
Therapeutically active fused pyrimidine derivatives. A series of monocyclic or bicyclic diamine-s... |
|
|
Invention
|
Protein involved in ovarian cancer. The present invention relates to new uses of CDCP1 in the dia... |
|
|
Invention
|
Bacterial host strain expressing recombinant dsbc. The present invention provides a recombinant g... |
|
2011
|
G/S
|
Magazine. Opération d'un site web traitant de l'épilepsie. |
|
|
G/S
|
Advocacy program to promote awareness about epilepsy. |
|
2010
|
G/S
|
Programme d'aide aux patients atteints de la maladie de Crohn et aux patients atteints d'arthrite... |
|
|
G/S
|
Providing personal support services, namely providing discussion group meetings, support group me... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of the central nervous system, namely epilepsy. Me... |
|
2009
|
G/S
|
Charitable services namely, patient assistance program to provide patients with drug reimbursemen... |
|
|
G/S
|
Administering medication reimbursement programs and services Charitable services, namely, providi... |
|
2008
|
G/S
|
Pharmaceutical preparations for the treatment of central nervous system diseases, namely central ... |
|
2007
|
G/S
|
Pharmaceutical preparations and substances. |
|
2006
|
G/S
|
Anti-inflammatory pharmaceutical preparations, namely preparations for the treatment of Crohn's d... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary products; dietetic
substances adapted for medical use, f... |
|
2005
|
G/S
|
Produits pharmaceutiques, vétérinaires et hygiéniques;
substances diététiques à usage médical, a... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations;
dietetic substances adapted for medical us... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
|
|
G/S
|
Préparations pharmaceutiques anti-inflammatoires, nommément préparations pharmaceutiques destinée... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
2003
|
G/S
|
Pharmaceutical preparations, namely, preparations for the treatment of [ infectious diseases, can... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
1996
|
G/S
|
Produits et spécialités pharmaceutiques. |
